AtriCure (ATRC) Stock Outlook 2026: Betting on Afib Ablation and Left Atrial Appendage Management
AtriCure (ATRC) stock outlook 2026: a qualitative deep dive into the surgical Afib ablation and AtriClip left atrial appendage management business, the guideline tailwind driving adoption, why the company still runs a net loss, and the pulsed field ablation competitive threat.